About

Reporter for Labiotech. I hail from the UK. I was born in Bristol, studied Neuroscience in the University of Bristol, and trained mice in Eisai, Hertfordshire, for one year. I then tickled locusts for my Ph.D. at the University of Leicester, before eventually ending up here!
Out of the office, I travel, play video games and board games, drink beer and play the piano.

Articles by Jonathan Smith

More News! 20 Nov 2019

€39M Series B to Fund Biopolymers for Surgery and Implants

CRISPR Cell Therapy Shows Early Promise for Treating Blood Disorders

US-French Deal to Tailor Ultrasound Therapy to Brain Cancer Patients

Update: Single-Shot Vaccine for Chikungunya Lasts for a Year in Phase I

Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential

Mass Layoffs as Dutch Biotech Cancels Phase III Cell Therapy Trial

ADVERTISEMENT

First Results Out for Off-the-Shelf CAR-T Therapy in Solid Tumors

Argenx Raises Whopping €502M in Global Offering

More News! 11 Nov 2019

Mereo BioPharma’s Brittle Bone Disease Drug Stumbles in Phase II

More News! 7 Nov 2019

Avantium Builds 10-Ton Demonstration Plant to Produce Bioplastics

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

UK Biotech Launched to Target ‘Dark Antigens’ with Cancer Vaccines

ADVERTISEMENT